Revolutions Medical Signs Distribution Agreement With McKesson
CHARLESTON, SC, Nov 16, 2012 (Menafn - MARKETWIRE via COMTEX) --Revolutions Medical Corporation (otcqb:RMCP) announced today thatthe Company has entered into a vendor and distribution agreement withMcKesson Corporation ("McKesson") for the distribution of theCompany's RevVac(TM) auto-retractable vacuum safety syringe in theUnited States healthcare market. McKesson is one of the leadingmedical-surgical supply and distribution companies in the UnitedStates, while also serving as one of the country's largestpharmaceutical distributors, supplying more than 40,000 pharmacylocations across the U.S. Pursuant to the terms of the vendor anddistribution agreement, the RevVac(TM) auto-retractable vacuum safetysyringe is now available to over 550 McKesson sales representativesthrough their distribution network and order processing system.
Ron Wheet, the Company's Chief Executive Officer and Chairman,stated, "Since introducing the RevVac(TM) safety syringe to the U.S.health care market in the second quarter 2012, the Company hasconsidered several available options to best manage the roll out ofour product. We are very pleased to have the RevVac(TM) safetysyringe distributed by McKesson, one of the best names in health carequality in the world. We believe this relationship will complementour additional sales efforts with MedPro Associates."
About Revolutions Medical Corporation
Revolutions Medical Corporation is a safety medical device andsoftware application company. Its proprietary technologies andproducts include: the RevVac(TM) safety syringe, safety blood drawingdevice, the RevColor(TM), RevDisplay(TM), and Rev3D(TM) softwaretools that are compatible with standard MRIs and standard PictureArchiving Computer Systems (PACS) and prefilled vacuumauto-retraction safety syringes.
For additional information, please visit Revolutions Medicalcorporate website: http://www.revolutionsmedical.com/
To be added to the Revolutions Medical investor email list, pleaseemail: investment@revolutionsmedical.com with RMCP in the subjectline.
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements.These statements relate to future events or to our future financialperformance, and involve known and unknown risks, uncertainties andother factors that may cause our actual results, levels of activity,performance, or achievements to be materially different from anyfuture results, levels of activity, performance or achievementsexpressed or implied by these forward-looking statements. You shouldnot place undue reliance on forward-looking statements since theyinvolve known and unknown risks, uncertainties and other factorswhich are, in some cases, beyond our control and which could, andlikely will, materially affect actual results, levels of activity,performance or achievements. Any forward-looking statement reflectsour current views with respect to future events and is subject tothese and other risks, uncertainties and assumptions relating to ouroperations, results of operations, growth strategy and liquidity. Weassume no obligation to publicly update or revise theseforward-looking statements for any reason, or to update the reasonsactual results could differ materially from those anticipated inthese forward-looking statements, even if new information becomesavailable in the future.
CONTACT:
Revolutions Medical Corporation
Investor Relations
Tel.: (843) 606-9461
SOURCE: Revolutions Medical Corporation
Copyright 2012 Marketwire, Inc., All rights reserved.
